140 related articles for article (PubMed ID: 2257219)
1. Distribution of pimonidazole and RSU 1069 in tumour and normal tissues.
Cobb LM; Nolan J; Butler SA
Br J Cancer; 1990 Dec; 62(6):915-8. PubMed ID: 2257219
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic distribution of [14C]-labelled pimonidazole in rhabdomyosarcoma-bearing rats and pigmented mice.
Laurent F; Benard P; Canal P; Soula G
Cancer Chemother Pharmacol; 1988; 22(4):308-15. PubMed ID: 3168144
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
Binger M; Workman P
Cancer Chemother Pharmacol; 1991; 29(1):37-47. PubMed ID: 1742848
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.
Walton MI; Workman P
Cancer Chemother Pharmacol; 1988; 22(4):275-81. PubMed ID: 3168141
[TBL] [Abstract][Full Text] [Related]
5. Microscopic distribution of misonidazole in mouse tissues.
Cobb LM; Nolan J; O'Neill P
Br J Cancer; 1989 Jan; 59(1):12-6. PubMed ID: 2757919
[TBL] [Abstract][Full Text] [Related]
6. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
[TBL] [Abstract][Full Text] [Related]
7. Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice.
Cole S; Stratford IJ; Bowler J; Nolan J; Wright EG; Lorimore SA; Adams GE
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):387-95. PubMed ID: 2061115
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of 2-nitroimidazole hypoxic cell radiosensitizers in rodent peripheral nervous tissue.
Sasai K; Shibamoto Y; Takahashi M; Ito T; Nishimoto S; Abe M
Int J Radiat Biol; 1990 May; 57(5):971-80. PubMed ID: 1970998
[TBL] [Abstract][Full Text] [Related]
9. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
Cole S; Stratford IJ; Fielden EM; Adams GE; Leopold W; Elliott W; Suto M; Sebolt-Leopold J
Int J Radiat Oncol Biol Phys; 1992; 22(3):545-8. PubMed ID: 1735694
[TBL] [Abstract][Full Text] [Related]
10. Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.
Stratford IJ; Adams GE; Godden J; Howells N
Int J Radiat Biol; 1989 Mar; 55(3):411-22. PubMed ID: 2564037
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic/pharmacokinetic evaluation of emesis induced by analogs of RSU 1069 and its control by antiemetic agents.
Sebolt-Leopold JS; Vincent PW; Beningo KA; Elliott WL; Leopold WR; Heffner TG; Wiley JN; Stier MA; Suto MJ
Int J Radiat Oncol Biol Phys; 1992; 22(3):549-51. PubMed ID: 1531213
[TBL] [Abstract][Full Text] [Related]
12. Interactions of hyperthermia with hypoxic cell sensitisers.
Bleehen NM; Walton MI; Workman P
Recent Results Cancer Res; 1988; 109():136-48. PubMed ID: 2972029
[No Abstract] [Full Text] [Related]
13. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
Hill RP; Gulyas S; Whitmore GF
Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
Grönroos T; Bentzen L; Marjamäki P; Murata R; Horsman MR; Keiding S; Eskola O; Haaparanta M; Minn H; Solin O
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):513-20. PubMed ID: 14722675
[TBL] [Abstract][Full Text] [Related]
15. Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
Hofer KG; Lakkis M; Hofer MG
Cancer; 1989 Apr; 63(8):1501-8. PubMed ID: 2924258
[TBL] [Abstract][Full Text] [Related]
16. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.
Walling J; Stratford IJ; Adams GE; Stephens MA
Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr; 53(4):641-9. PubMed ID: 3258298
[TBL] [Abstract][Full Text] [Related]
17. Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.
Parliament MB; Wiebe LI; Franko AJ
Br J Cancer; 1992 Dec; 66(6):1103-8. PubMed ID: 1280990
[TBL] [Abstract][Full Text] [Related]
18. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
[TBL] [Abstract][Full Text] [Related]
19. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
[TBL] [Abstract][Full Text] [Related]
20. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
Siemann DW
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
